The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to QIAGEN LLC, 19300 Germantown Road, Germantown, MD 20874,1414 to provide a Roto-Gene Q MDx (US) Platform. The QIAGEN Roto Gene instrument is FDA approved and the software is compatible with the CDC Assay. This instrument will be qualified for use with FDA EUA cleared CDC MERS CoV Real-Time RT-PCR Assa to be used by US Public Health laboratories. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at [email protected] by COB August 16, 2019

Bid Protests Not Available